Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.2 is shown, replacing the previous v3.3.1. This appears to be a minor frontend update that does not alter study details or functionality.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded clarifications that publications are provided voluntarily and are automatically filled from PubMed, and noted Revision: v3.3.1. The prior language implying PubMed articles are automatically generated and may relate to the study results was removed.SummaryDifference0.2%

- Check16 days agoChange DetectedRemoval of the government funding status notice at the bottom of the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe new screenshot shows only minor UI/layout adjustments with no updates to core trial data (title, conditions, interventions, eligibility criteria, primary outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check59 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

- Check66 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.1%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.